Kabra Drugs Ltd. - Research Center
524322 KABRADG Group (XT) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Sales | - | - | - | - | 0.02 |
| Operating profit | -0.74 | -0.34 | -0.18 | -0.15 | -0.03 |
| Interest | - | - | - | - | - |
| Gross profit | -0.74 | -0.34 | -0.18 | -0.15 | -0.03 |
| EPS (Rs) | -1.68 | -0.77 | -0.42 | -0.41 | -0.14 |
Annual
results in details
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Other income | - | 0.01 | - | - | - |
| Stock adjustment | - | - | - | - | - |
| Raw material | - | - | - | - | - |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 0.40 | 0.23 | 0.09 | 0.05 | - |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 0.34 | 0.11 | 0.09 | 0.10 | 0.05 |
| Provisions made | - | - | - | - | - |
| Depreciation | - | - | 0.01 | 0.03 | 0.03 |
| Taxation | - | - | - | - | - |
| Net profit / loss | -0.74 | -0.34 | -0.19 | -0.18 | -0.06 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 4.39 | 4.39 | 4.39 | 4.39 | 4.39 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | - | - | - | - | -120.98 |
| GPM (%) | - | - | - | - | - |
| NPM (%) | - | - | - | - | - |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis